Capital Impact Advisors, LLC - JUNO THERAPEUTICS INC ownership

JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109. A total of 214 filers reported holding JUNO THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.99 and the average weighting 0.9%.

Quarter-by-quarter ownership
Capital Impact Advisors, LLC ownership history of JUNO THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$1,262,000
+1.9%
27,6020.0%0.54%
-1.4%
Q3 2017$1,238,00027,6020.55%
Other shareholders

There were no reported owners of JUNO THERAPEUTICS INC in Q3 2017.

NameSharesValueWeighting ↓
View complete list of JUNO THERAPEUTICS INC shareholders